Pharma Journalist - Page 75 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

argenx Wins FDA Approval for VYVGART Hytrulo Self-Injection

Cingulate Secures $3M Grant to Advance Anxiety Drug CTx-2103 (Buspirone)

FDA Approves Biocon’s Jobevne, Bevacizumab Biosimilar

FDA to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Drugs

Renovaro and BioSymetrics Complete Merger to Boost AI-Driven Biomarker Discovery and Precision Medicine

Epsilogen Acquires TigaTx to Lead Pan-Isotype Cancer Antibody Market

ALX Oncology Gets FDA IND Clearance for EGFR-targeted Antibody-Drug Conjugate ALX2004

Avidity Biosciences Wins Orphan Drug Designation in Japan for Delpacibart Etedesiran

Engine Biosciences and EDDC Partner to Advance Cancer Therapies

Poxel Gains Approval to Expand TWYMEEG Indication for Type 2 Diabetes with Renal Impairment in Japan